Search

Issue
Title
Authors
Knowledge of senior students in the definition, classification, and approaches to the treatment of arterial hypertension. Final results of the PHYSTARH project
Bontsevich R.A., Vovk Y.R., Gavrilova A.A., Batishcheva G.A., Goncharova N.I., Elizarova I.O., Ketova G.G., Barysheva V.O., Bikkinina G.M., Myronenko O.V.
Blood pressure variability, endothelial dysfunction, and C-reactive protein levels in arterial hypertension in combination with coronary artery disease
Musikhina N.A., Petelina T.I., Gapon L.I., Kostousova A.I.
The efficiency of two-level electrovectorcardiographic diagnostics of left ventricular hypertrophy in the medical examination of urban and rural population
Riabykina G.V., Vishniakova N.A., Fedorova V.S.
Management of patients with arterial hypertension and atrial fibrillation
Chazova I.E., Golitsyn S.P., Zhernakova J.V., Zheleznova E.A., Kropacheva E.S., Mironov N.I., Kostiukevich M.V., Laiovich L.I., Utsumueva M.D., Iuricheva I.A., Litvin A.Y., Elfimova E.M., Rogoza A.N., Panchenko E.P.
Predictors of cardiovascular complications in patients with arterial hypertension and comorbid pathology
Murkamilov I.T., Fomin V.V., Yusupov F.A., Sabirov I.S.
Drug-induced arterial hypertension
Ostroumova O.D., Kulikova M.I.
Demographic and clinical differences between idiopathic and scleroderma-related pulmonary arterial hypertension: Russian National Registry analysis
Yudkina N.N., Valeeva E.G., Taran I.N., Nikolaeva E.V., Paramonov V.M., Kurmukov I.A., Valieva Z.S., Arkhipova O.A., Martynyuk T.V., Volkov A.V., Nasonov E.L., Chazova I.E.
The validation of the questionnaire for the early detection of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Valieva Z.S., Glukhova S.I., Martyniuk T.V., Chazova I.E.
The development of a screening questionnaire to improve the early detection of pulmonary arterial hypertension
Valieva Z.S., Valeeva E.G., Glukhova S.I., Martynyuk T.V., Chazova I.E.
Clinical practice guidelines on the diagnosis and treatment of patients with arterial hypertension and chronic obstructive pulmonary disease
Chazova I.E., Nevzorova V.A., Ambatiello L.G., Brodskaia T.A., Oshchepkova E.V., Belevskii A.S., Zhernakova J.V., Aisanov Z.R., Ovcharenko S.I., Chuchalin A.G.
Drug therapy of arterial hypertension: assessment of the physicians’ basic knowledge. Final results of the PHYSTARH project
Bontsevich R.A., Vovk Y.R., Gavrilova A.A., Kirichenko A.A., Krotkova I.F., Kosmacheva E.D., Kompaniets O.G., Prozorova G.G., Nevzorova V.A., Martynenko I.M., Ketova G.G., Barysheva V.O., Maksimov M.L., Osipova O.A.
Uncontrolled arterial hypertension: main causes, features of pathogenesis and approaches to treatment
Denisova A.R., Solntseva T.D., Sivakova O.A., Chazova I.E.
Uncontrolled arterial hypertension in patients with breast cancer and the risk of developing cardiotoxicity with anthracycline-containing chemotherapy
Oshchepkova E.V., Avalyan A.A., Rogoza A.N., Gorieva S.B., Saidova M.A., Chazova I.E.
The possibility of a new receptor blocker to angiotensin in improving control of hypertension. Non-intervention international multicenter observational prospective study of the use azilsartan medoxomil in patients with arterial hypertension and overweight or obesity in the Russian Federation and the Republic of Kazakhstan
Zhernakova Y.V., Chazova I.E.
Features of the use of torasemide in arterial hypertension
Baryshnikova G.A., Chorbinskajya S.A.
Quality assessment of examination of patients with arterial hypertension in primary health care (according to the Russian arterial hypertension register data)
Oshchepkova E.V., Lazareva N.V., Chazova I.E.
Clinical features and course of arterial hypertension in patients with its various forms
Denisova A.R., Esaulova T.E., Solntseva T.D., Sivakova O.A., Chazova I.E.
Etiopathogenesis, diagnosis, and approaches to the treatment of arterial hypertension: an assessment of the physicians’ basic knowledge. Final results of the PHYSTARH project
Bontsevich R.A., Vovk Y.R., Gavrilova A.A., Kirichenko A.A., Ebzeeva E.Y., Kosmacheva E.D., Kompaniets O.G., Prozorova G.G., Nevzorova V.A., Martynenko I.M., Barysheva V.O., Ketova G.G., Maksimov M.L., Osipova O.A.
Possibilities of treatment of patients with resistant arterial hypertension
Shugushev Z.K., Maximkin D.A., Ryumina A.S.
Workplace hypertension": focus on emotional and personality traits in patients
Ostroumova O.D., Pervichko E.I., Zinchenko Y.P.
Features of cutaneous microcirculatory blood flow in patients with pulmonary hypertension of different etiology
Dolgova E.V., Fedorovich A.A., Martynyuk T.V., Rogoza A.N., Chazova I.E.
Myocardial ischemia in patients with pulmonary arterial hypertension
Arkhipova O.A., Martyniuk T.V., Valeeva E.G., Ryabykina G.V., Samoylenko L.E., Sergienko V.B., Chazova I.E.
Modernization of hypertension treatment in the Yaroslavl region: interim results of the yearly comprehensive program for modernization of the regional healthcare system
Mozheyko M.E., Eregin S.Y., Vigdorchik A.V., Klimovskaia I.M., Riahi F., Hughes D.
Evaluation of effectiveness and safety of the first Russian-manufactured generic bosentan use in patients with pulmonary arterial hypertension
Arkhipova O.A., Gratsianskaya S.E., Martynyuk T.V.
Specificity of the effect of double fractures of the rhythmogram on the daily variability of the sinus rhythm in patients with pulmonary and arterial hypertension
Sobolev A.V., Ryabykina G.V., Kozhemyakina E.S.
Clinical Manual for Diagnosis, Prevention and Treatment of Cardiovascular Complications of Cancer Therapy. Parts II-V
Chazova I.Y., Tyulyandin S.A., Vitsenia M.V., Poltavskaya M.G., Gilyarov M.Y., Martynyuk T.V., Ovchinnikov A.G., Panchenko E.P., Fedotkina Y.A., Stenina M.B., Trophimova O.P., Ageev F.T.
Clinical, functional and hemodynamic profile of patients with Eisenmenger syndrome in comparison with the group of idiopathic pulmonary hypertension, features of starting specific therapy choice
Gratsianskaya S.E., Valieva Z.S., Zorin A.V., Martynyuk T.V.
Endothelin receptor antagonist bosentan role in modern strategy for patients with pulmonary arterial hypertension treatment
Arkhipova O.A., Martynyuk T.V.
Quality of life in patients with idiopathic pulmonary hypertension: the first experience of trimetazidine
Kuznetsova E.G., Glukhova S.I., Martynyuk T.V., Nakonechnikov S.N., Chazova I.E.
Chronic myocardial damage in idiopathic pulmonary arterial hypertension: a clinical case
Bykov A.N., Arkhipov M.V., Klimusheva N.F., Iofin A.I., Krokhalev V.Y.
Implementation of the organoprotective properties of fixed combinations of valsartan, amlodipine and hydrochlorothiazide (Vamloset® and Co-Vamloset) in patients with grade 2 and 3 hypertension in the Russian clinical study VICTORY II
Chazova I.E., Martynyuk T.V., Rodnenkov O.V., Gorieva S.B., Rogoza A.N., Arkhipov M.V., Grinshtein Y.I., Ostroumova O.D., Galiavich A.S., Rotar’ O.P., Khaisheva L.A., Kameneva T.R.
Vascular stiffness in patients with arterial hypertension: possible antihypertensive therapy
Ostroumova O.D., Kochetkov A.I., Lopukhina M.V.
Effect of renal denervation on the arterial stiffness and central hemodynamics in patients with resistant hypertension
Shchelkova G.V., Zairova A.R., Danilov N.M., Rogoza A.N., Chazova I.E.
Organoprotective properties of therapy by fixed combination of perindoprile and amlodipine in patients with arterial hypertension and diabetes mellitus type 2
Statsenko M.E., Turkina S.V., Titarenko M.N.
The effect of combined antihypertensive therapy on arterial wall rigidity in male patients with hypertension, obesity and obstructive sleep apnea
Elfimova E.M., Zairova A.R., Andrievskaya M.V., Bogieva R.M., Rogoza A.N., Litvin A.Y.
Comparative characteristics of indicators of peripheral arterial and central aortic pressure, remodeling of the left ventricular myocardium in salt-sensitive and salt-resistant patients with arterial hypertension
Skibitskiy V.V., Vasil'ev V.Y., Fendrikova A.V., Pyatakov S.N.
Expert consensus. Effect of antihypertensive therapy on cognitive functions
Ostroumova O.D., Parfenov V.A., Ostroumova T.M., Yakhno N.N., Chazova I.E., Bogolepova A.N., Galyavich A.S., Geraskina L.A., Emelin A.I., Zakharov V.V., Kislyak O.A., Kulesh A.A., Levin O.S., Podzolkov V.I., Privalova E.V., Shikh E.V.
First results of Russian multicenter prospective clinical study VICTORY II: Vamloset® and Co-Vamloset effectiveness and safety in patients with stage 2 and 3 arterial hypertension
Chazova I.E., Martynyuk T.V., Rodnenkov V.O., Gorieva B.S., Rogoza A.N., Arkhipov M.V., Grinshtein Y.I., Ostroumova O.D., Galiavich A.S., Rotar’ O.P., Haisheva L.A., Kameneva T.R.
Target blood pressure levels in patients with arterial hypertension and frailty
Ostroumova O.D., Cherniaeva M.S., Morozov A.P.
Direct renin inhibitors aliskiren - possibilities correction cardiorenal syndrome
Chazova I.E., Fomin V.V.
Possible combinations of antihypertensive drugs at treatment of arterial hypertension at patientswith metabolic syndrome
Mychka V.B., Chazova I.E., Mychka V.B., Chazova I.E.
The role of angiotensin receptor antagonists in treatment of arterial hypertension: focus on losartan
Baryshnikova G.A., Baryshnikova G.A.
Combined antihypertensive therapy in the light of modern recommendations: strategy of one tablet
Morozova T.E.
The relationship between the antihypertensive effect of b-adrenergic blockers and the initial daily variability of sinus rhythm
Sobolev A.V., Talabanov P.G., Ryabykina G.V., Kozhemyakina E.S.
Guidelines for diagnostics and treatment of hypertension 2018 - European experts’opinion [Guidelines]
Chazova I.E., Zhernakova Y.V.
Pulmonary hypertension: reasonable selection of specific therapy
Karoli N.A., Sazhnova S.I., Rebrov A.P.
Markers of early cardiotoxicity in patients with breast cancer undergoing chemotherapy depending on blood pressure level
Avalyan A.A., Kirillova M.Y., Shitov V.N., Oshchepkova Y.V., Saidova M.A., Stenina M.B., Chazova I.Y.
The effect of combined therapy on the properties of the vessel wall in patients at high risk of cardiovascular complications
Blankova Z.N., Aslanyan N.S.
The effect of antihypertensive therapy and CPAP therapy on inflammatory and endothelial dysfunction markers levels in patients with severe obstructive sleep apnea syndrome in association with arterial hypertension
Elfimova E.M., Rvacheva A.V., Tripoten M.I., Pogorelova O.V., Balakhonova T.V., Zykov K.A., Litvin A.Y.
A fixed combination of amlodipine and losartan: effectiveness and safety in abnormal weather conditions in patients with arterial hypertension
Ageev F.T., Smirnova M.D., Fofanova T.V., Blankova Z.N., Vitsenya M.V., Tsybulskaya T.V., Neverova E.F., Samsonova N.S.
Diuretics in combination antihypertensive therapy: focus on forecast
Chazova I.E., Martyniuk T.V.
Treatment with perindopril in patients with arterial hypertension: improving compliance
Anikin G.S., Minina E.S., Andreevskaya E.M.
The meaning of hypertensive therapy choice in the correction of cerebral affection: from mild cognitive impairment to dementia
Shishkova V.N.
The role of beta-blockers in the treatment of arterial hypertension: what do we know today
Zhernakova Y.V., Chazova I.E.
The application of torasemide in patients with arterial hypertension: evidence-based and practical approaches
Gilyarevsky S.R., Kuzmina I.M., Golshmid M.V.
The treatment options of the new angiotensin II receptor blocker - azilsartan medoxomil in the therapy of hypertension in patients with metabolic disorders
Zhernakov Y.V., Chazova I.Y.
The problem of determining the efficiency of treatmentin the era of evidence-based medicine: international and domestic experience
Gilyarevsky S.R.
The results of the open observational, international, multicenter, prospective program to assess the efficacy, safety and tolerability of the first direct renin inhibitor RasilezR (aliskiren) in patients with arterial hypertension in ‘real-life’ clinical practice settings (DRIve)
Chazova I.Y.
Risk of target organ damage in patients with arterial hypertension and various numbers of metabolic syndrome components
Zhernakova Y.V., Sharipova G.K., Chazova I.E.
Rational pharmacotherapy of hypertension. Urapidil potential
Morozova T.E., Andruschishina T.B., Shmarova D.G.
Effect of angiotensin II receptor antagonists on left ventricular hypertrophy, vascular elasticity, and lipid and carbohydrate metabolic parameters in metabolic syndrome
Nedogoda S.V., Salasyuk A.S., Chalyabi T.A., Barykina I.N., Pocheptsov D.A., Ledyaeva A.A., Tsoma V.V., Chumachek E.V.
Iloprost for acute tests in patients with pulmonary arterial hypertension
Belyatko E.A., Danilov N.M., Matchin Y.G., Martynyuk T.V., Chazova I.E.
HYVET: landmark trial voted 2008 Trialof the Year by the ImpACT/Society for Clinical Trials and the American Heart Association
Prevalence of risk factors for arterial hypertension among draft age youth
Uvarovskaia B.V., Mel’nik M.V., Kniazeva S.A.
Combined antihypertensive and psychocorrective therapy in patients with arterial hypertension and anxiety-depressive disorders: are there any advantages?
Skibitsky V.V., Ginter J.E., Fendrikova A.V., Sirotenko D.V.
Renal artery denervation in patients with resistant arterial hypertension: clinical and organ-protective effect
Gapon L.I., Mikova E.V., Krinochkin D.V., Savelyeva N.Y., Zherzhova A.Y., Aleksandrovich E.L.
Clinical guidelines on arterial hypertension diagnosis, treatment and prevention in children and adolescents
Aleksandrov A.A., Kisliak O.A., Leontyeva I.V.
Risk factors for falls in patients with arterial hypertension
Khovasova N.O., Naumov A.V., Tkacheva O.N., Moroz V.I.
The improved form perindopril in treatment of arterial hypertension in various clinical situations (PREMIA)
Mychka V.B., Zhernakova Y.V., Chazova I.E.
The use of angiotensin receptor blocker losartan in the combinational therapy of arterial hypertension
Zagidullin N.S., Zagidullin S.Z.
Efficacy of the fixed combination β-blocker and calcium antagonist Logimax at women with an essential hypertensionin different age groups
Ostroumova O.D., Zhukova O.V., Golovina O.V., Srednyakov A.V., Otdelenov A.V.
The role of b-blockers in the new revision of the 2018 European guidelines for the diagnosis and treatment of arterial hypertension in the patients with comorbidities
Ostroumova O.D., Kochetkov A.I.
Stroke prevention in patients with atrial fibrillation and comorbidities
Ostroumova O.D., Voevodina N.Y., Guseva T.F., Pavleeva E.E., Piksina G.F., Goloborodova I.V.
The problem of broncho-obstructive syndrome early detection in cardiological patients. Review of specialized respiratory questionnaires and their use in patients with comorbid cardiovascular and broncho-obstructive pathologies
Klimova A.A., Ambatello L.G., Smolyakova E.V., Nistor S.Y., Zykov K.A., Chazova I.E.
Markers of early target-organ brain damage in essential arterial hypertension: the search continues. Possibilities of diffusion tensor magnetic resonance imaging
Parfenov V.A., Ostroumova T.M., Ostroumova O.D., Perepelova E.M., Perepelov V.A.
Advantages azilsartan medoxomil in patients with arterial hypertension: how to make a choice and to optimize antihypertensive therapy?
Martynyuk T.V., Chazova I.E.
Treatment of patients with high cardiovascular risk: a modern view on combined therapy
Blankova Z.N., Aslanian N.S., Smolianinova N.G., Ageev F.T.
Radiofrequency renal arteries denervation: effectively and safely
Grigin V.A., Danilov N.M., Matchin Y.G., Chazova I.E.
Loop diuretics in the treatment of hypertension and edema syndrome
Kirichenko A.A.
Current possibilities of nuclear imaging in arterial hypertension
Ansheles A.A., Sergienko V.B.
Longitudinal deformation of the left ventricle and the left atrium in workers of railway transport with arterial hypertension
Marsalskaya O.A., Nikiforov V.S.
Fixed dose combinations for the treatment arterial hypertension: the real way to improve control
Morozova T.E., Andreev S.S.
The recommendations review concerning the maintenance of patients with arterial hypertension: evidence and expert opinions
Samorodskaya I.V., Boitsov S.A.
Fibromuscular dysplasia as the cause of malignant renovascular hypertension in a newborn
Albot V.V., Dolgikh V.V., Gvak G.V., Pogodina A.V.
Nebivolol for treatment patients with arterial hypertension
Mikheeva O.M., Komisarenko I.A.
Effect of sildenafil on clinical evidence and hemodynamic parameters in patients with pulmonary arterial hypertension, associated withsystemic rheumaticdiseases
Volkov A.V., Udkina N.N., Kurmukov I.A., Nikolaeva Y.A., Nasonov Y.L.
Angiotensin II receptor blockers in the treatment of arterial hypertension in patients with concomitant pathology: focus on candesartan
Trukhan D.I.
Recommendations on treatment strategies in hypertensivepatientswithmetabolic disorders
Zhernakova Y.V., Chazova I.E.
Place of angiotensin receptor blockers in antihypertensive therapy
Martynov A.I., Urlaeva I.V., Akatova E.V., Nikolin O.P.
A modern phylogenetic theory of pathology, pathogenesis of essential arterial hypertension and universal algorhythm of damage to the target organs
Titov V.N.
The place of Indapamide retard in the treatment of patients with left ventricular dysfunction and preserved systolic function in the presence of arterial hypertension
Tereshchenko S.N., Zhirov I.V.
Stress-induced arterial hypertension – clinical features and treatment options
Ratova L.G., Chazova I.E.
Sartans in cardiological practice: new possibilities in therapy of cardiovascular diseases
Smolenskaya O.G.
Russian medical society on arterial hypertension (RMSAH) Consensus of Experts on the use of radiofrequency denervation of the renal arteries in patients with arterial hypertension
Danilov N.M., Agaeva R.A., Matchin Y.G., Grigin V.A., Shchelkova G.V., Ripp T.M., Pekarskii S.E., Baev A.E., Chazova I.Е.
Gender-age peculiarities of smoking and diabetes mellitus role in the development of myocardial infarction in patients with arterial hypertension
Aksenova A.V., Oshchepkova E.V., Orlovsky A.A., Chazova I.E.
Consensus on patients with hyperuricemia and high cardiovascular risk treatment
Chazova I.E., Zhernakova J.V., Kisliak O.A., Nedogoda S.V., Podzolkov V.I., Oshchepkova E.V., Medvedeva I.V., Mironova O.I., Blinova N.V.
Fleita is a Russian randomized, open-label, multicenter, comparative program for the evaluation of the efficacy and safety of the fixed combination drug Tarka (ABBOTT Laboratories, USA) versus optional sustained-release antihypertensive drugs in the treatment of patients with arterial hypertension and cognitive disorders (stepwise strategy)
Chazova I.E., Ostroumova O.D.
Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients withtype 2 diabetes mellitus and mild hypertension:a sequential, randomized, double-blind clinical trial
Giuseppe Derosa -., Arrigo FG Cicero -., Angela D'Angelo -., Elena Fogari -., Sibilla Salvadeo -., Alessia Gravina -., Ilaria Ferrari -., Raffaella Fassi -., Roberto Fogari -.
Arterial hypertension and treatment of non steroidal anti-inflammatory drugs: advantage amlodipin
Ezhov M.V., Yezhov M.V.
Communication of subcutaneous, visceral, periaortic, epicardial fat and metabolic parameters with arterial stiffness in young people with abdominal obesity
Zheleznova E.A., Zhernakova Y.V., Chazova I.E., Rogoza A.N., Zairova A.R., Shariya M.A., Yarovaya E.B., Orlovsky A.A., Blinova N.V., Azimova M.O., Gorieva S.B., Konosova I.D.
1 - 100 of 255 Items 1 2 3 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies